Financial News · Live Terminal

Page 118 of 316

Leerink Partners Downgrades Regeneron Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $641 From $792

Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $852.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

Leerink Partners Downgrades Regeneron Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $641 From $792

Sushil Finance Starts Affle (India) at Buy with INR2,033 Price Target

Choice Equity Downgrades United Spirits to Reduce from Add; Price Target is INR1,230

ICICIdirect.com Starts Steel Authority of India at Buy with INR240 Price Target

Phillip Securities Downgrades Carabao Group to Accumulate from Buy; Price Target is THB43.25

CLSA Downgrades Hanmi Semiconductor to Hold from Accumulate, Price Target is KRW325,000

Fubon Securities Downgrades VisEra Technologies to Neutral from Buy; Price Target is NT$565

Choice Equity Downgrades Data Patterns (India) to Add from Buy; Price Target is INR4,060

Choice Equity Downgrades Centum Electronics to Add from Buy; Price Target is INR3,300

Hanwha Upgrades Korean Reinsurance to Buy from Hold; Price Target is KRW19,000

Nomura Upgrades Haseko to Buy from Neutral; Price Target is 3,490 Yen

Phillip Securities Upgrades SIA Engineering Company to Buy from Accumulate; Price Target is SG$4.06

RBC Initiates National Healthcare Properties at Sector Perform With $15 Price Target

Macquarie Downgrades Swiggy to Underperform from Neutral; Price Target is INR230

Choice Equity Downgrades Azad Engineering to Reduce from Buy; Price Target is INR1,900

Bualuang Securities Downgrades SIS Distribution Thailand to Hold from Buy; Price Target is THB24

GuoSen Securities Starts Jingdong Industrials at Outperform with HK$21.15 Price Target

Morgan Stanley Initiates National Healthcare Properties at Equalweight With $16 Price Target

Prabhudas Lilladher Downgrades VIP Industries to Sell from Reduce, Price Target is INR245

William O'Neil Initiates Bank of New York Mellon at Buy

Leerink Partners Downgrades Regeneron Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $641 From $792

Sushil Finance Starts Affle (India) at Buy with INR2,033 Price Target

Choice Equity Downgrades United Spirits to Reduce from Add; Price Target is INR1,230

ICICIdirect.com Starts Steel Authority of India at Buy with INR240 Price Target

Phillip Securities Downgrades Carabao Group to Accumulate from Buy; Price Target is THB43.25

CLSA Downgrades Hanmi Semiconductor to Hold from Accumulate, Price Target is KRW325,000

Fubon Securities Downgrades VisEra Technologies to Neutral from Buy; Price Target is NT$565

Choice Equity Downgrades Data Patterns (India) to Add from Buy; Price Target is INR4,060

Choice Equity Downgrades Centum Electronics to Add from Buy; Price Target is INR3,300

Hanwha Upgrades Korean Reinsurance to Buy from Hold; Price Target is KRW19,000

Nomura Upgrades Haseko to Buy from Neutral; Price Target is 3,490 Yen

Phillip Securities Upgrades SIA Engineering Company to Buy from Accumulate; Price Target is SG$4.06

RBC Initiates National Healthcare Properties at Sector Perform With $15 Price Target

Macquarie Downgrades Swiggy to Underperform from Neutral; Price Target is INR230

Choice Equity Downgrades Azad Engineering to Reduce from Buy; Price Target is INR1,900

Bualuang Securities Downgrades SIS Distribution Thailand to Hold from Buy; Price Target is THB24

GuoSen Securities Starts Jingdong Industrials at Outperform with HK$21.15 Price Target

Morgan Stanley Initiates National Healthcare Properties at Equalweight With $16 Price Target

Prabhudas Lilladher Downgrades VIP Industries to Sell from Reduce, Price Target is INR245

William O'Neil Initiates Bank of New York Mellon at Buy